Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

DNI Metals | Status on Trading, Fraud Trial, and Permits

DNI Metals (CSE: DNI | OTC: DMNKF) Dan Wei r of DNI Metals sits down with Maurice Jackson of Proven and Probable to provide shareholders updates on when trading will commence on the Canadian Stock Exchange, judicial ma...
Maurice Jackson | April 1, 2020 |

'Well-Planned, Accretive Acquisition' of Leagold Moves Equinox to Mid-Tier Status

The highlights and benefits of the transaction are provided in a Haywood report. In a Dec. 17 research note, Haywood analyst Kerry Smith purported that Equinox Gold Corp.'s (EQX:TSX.V) acquisition of Leagold Mining is "a good transaction at a good price" and recomme...
Streetwise Reports | December 27, 2019 |

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug

Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. In a June 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the U.S. Food and Drug Administration (FDA) designated Axsome Therapeutics...
Streetwise Reports | July 2, 2020 |

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug

Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. This morning, Hamilton, Bermuda based biopharmaceutical company ...
Streetwise Reports | November 21, 2019 |

Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment

Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP). This morning orphan lun...
Streetwise Reports | January 2, 2020 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Analyst: Gold Explorer Warrants Top Pick Status

The rationale for this view of the company is provided in an Echelon Wealth Partners report. In an Oct. 3 research note, analyst Gabriel Gonzalez reported that Echelon Wealth Partners continues to consider Revival Gold Inc. (RVG:TSX.V) a Top Pick, as the company's 2...
Streetwise Reports | October 9, 2019 |

Iron Ore & Vanadium in Quebec: Who’s Driving BOTH Markets?

(Click image to play podcast) One of the world’s least known metals also happens to be of immense importance and is likely to become even more so as renewable energies catch up with and, eventually, eclipse fossil fuels. If you don&CloseCurlyQ...
Dave Jackson | October 19, 2020 |

Leading Edge raising C$4.5M to supply European critical raw materials

Leading Edge Materials is offering a C$4.5 million non-brokered private placement Proceeds will be used to fund the company’s projects in Sweden and Romania The company has a 100 per cent stake in its Woxna Graphite Mine and Norra Karr ...
Coreena Robertson | July 19, 2024 |

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...
Research | October 30, 2024 |
1 2 3 4 5 6 7 8 9 10 ...